N.E.W. Advisory Services LLC Charles River Laboratories International, Inc. Transaction History
N.E.W. Advisory Services LLC
- $1.25 Billion
- Q1 2025
A detailed history of N.E.W. Advisory Services LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, N.E.W. Advisory Services LLC holds 21 shares of CRL stock, worth $3,758. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21Holding current value
$3,758% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
625Shares Held
55MCall Options Held
722KPut Options Held
847K-
Vanguard Group Inc Valley Forge, PA6.11MShares$1.09 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$911 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$767 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$428 Million0.07% of portfolio
-
Allspring Global Investments Holdings, LLC2.29MShares$410 Million0.63% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.1B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...